WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc., (NASDAQ:ENTA) a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, will make a formal company presentation on January 13, 2016, at 11:00 a.m. PT at the 34th Annual J.P. Morgan Healthcare Conference in San Francisco. The presentation will contain a business overview and an update on Enanta’s research and development pipeline. A question and answer session with investors will follow the presentation.
